{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:09:22Z","timestamp":1791828562073,"version":"4.3.4"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.ajo.2016.07.016","type":"journal-article","created":{"date-parts":[[2016,7,26]],"date-time":"2016-07-26T06:45:04Z","timestamp":1469515504000},"page":"32-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Anti-TNF\u03b1 Treatment for HLA-B27-Positive Ankylosing Spondylitis\u2013Related Uveitis"],"prefix":"10.1016","volume":"170","author":[{"given":"Mirinae","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Yon","family":"Won","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6519-6882","authenticated-orcid":false,"given":"Seung Yong","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Hyeon","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Hoon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ajo.2016.07.016_bib1","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s10067-012-1984-6","article-title":"Hearing and cochlear function of patients with ankylosing spondylitis","volume":"31","author":"Kahveci","year":"2012","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.ajo.2016.07.016_bib2","series-title":"Harrison's Principles of Internal Medicine","first-page":"2169","article-title":"The spondyloarthritides","author":"Taurog","year":"2015"},{"issue":"1","key":"10.1016\/j.ajo.2016.07.016_bib3","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/1529-0131(199801)41:1<58::AID-ART8>3.0.CO;2-G","article-title":"Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors","volume":"41","author":"Braun","year":"1998","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.ajo.2016.07.016_bib4","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/rheumatology\/ket387","article-title":"Global prevalence of ankylosing spondylitis","volume":"53","author":"Dean","year":"2014","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"10.1016\/j.ajo.2016.07.016_bib5","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/rheumatology\/36.7.766","article-title":"The outcome of ankylosing spondylitis: a study of 100 patients","volume":"36","author":"Gran","year":"1997","journal-title":"Br J Rheumatol"},{"issue":"11","key":"10.1016\/j.ajo.2016.07.016_bib6","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1136\/ard.2011.152975","article-title":"HLA-B27 positive patients differ from HLA-B27 negative patients in clinical presentation and imaging: results from the DESIR cohort of patients with recent onset axial spondyloarthritis","volume":"70","author":"Chung","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"4 Suppl 2","key":"10.1016\/j.ajo.2016.07.016_bib7","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/rheumatology\/XXII.suppl_2.144","article-title":"Acute anterior uveitis (AAU) and HLA-B27","volume":"22","author":"Rothova","year":"1983","journal-title":"Br J Rheumatol"},{"issue":"3","key":"10.1016\/j.ajo.2016.07.016_bib8","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0002-9394(14)76733-9","article-title":"Anterior uveitis and hypopyon","volume":"112","author":"D'Alessandro","year":"1991","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2016.07.016_bib9","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1080\/09273940490912461","article-title":"Clinical features and outcomes of HLA-b27-positive and HLA-B27-negative acute anterior uveitis in a Turkish patient population","volume":"13","author":"Tuncer","year":"2005","journal-title":"Ocul Immunol Inflamm"},{"issue":"4","key":"10.1016\/j.ajo.2016.07.016_bib10","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1136\/bjo.84.4.413","article-title":"HLA-B27 typing in the categorisation of uveitis in a HLA-B27 rich population","volume":"84","author":"Huhtinen","year":"2000","journal-title":"Br J Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2016.07.016_bib11","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s00296-006-0203-7","article-title":"Characterization and outcome of uveitis in 350 patients with spondyloarthropathies","volume":"26","author":"Sampaio-Barros","year":"2006","journal-title":"Rheumatol Int"},{"issue":"9","key":"10.1016\/j.ajo.2016.07.016_bib12","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/S0161-6420(98)99033-9","article-title":"Outcomes in anterior uveitis associated with the HLA-B27 haplotype","volume":"105","author":"Power","year":"1998","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ajo.2016.07.016_bib13","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1076\/ocii.7.2.85.4015","article-title":"Posterior segment inflammation in HLA-B27+ acute anterior uveitis: clinical characteristics","volume":"7","author":"Dodds","year":"1999","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.ajo.2016.07.016_bib14","doi-asserted-by":"crossref","first-page":"10411","DOI":"10.1146\/annurev.iy.10.040192.002211","article-title":"The pathophysiology of tumor necrosis factors","volume":"10","author":"Vassalli","year":"1992","journal-title":"Annu Rev Immunol"},{"issue":"5573","key":"10.1016\/j.ajo.2016.07.016_bib15","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1126\/science.1071924","article-title":"TNF-R1 signaling: a beautiful pathway","volume":"296","author":"Chen","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.ajo.2016.07.016_bib16","first-page":"8341","article-title":"Anti-TNF therapy for juvenile idiopathic arthritis-related uveitis","volume":"8","author":"Semeraro","year":"2014","journal-title":"Drug Des Devel Ther"},{"issue":"3","key":"10.1016\/j.ajo.2016.07.016_bib17","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1601-0825.2008.01440.x","article-title":"Biologic treatments for systemic rheumatic diseases","volume":"14","author":"Shirota","year":"2008","journal-title":"Oral Dis"},{"issue":"12","key":"10.1016\/j.ajo.2016.07.016_bib18","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1093\/rheumatology\/keu266","article-title":"Anti-TNF-alpha therapy in patients with refractory uveitis due to Behcet's disease: a 1-year follow-up study of 124 patients","volume":"53","author":"Calvo-Rio","year":"2014","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.ajo.2016.07.016_bib19","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1159\/000055677","article-title":"Aqueous humor and serum tumor necrosis factor-alpha in clinical uveitis","volume":"33","author":"Santos Lacomba","year":"2001","journal-title":"Ophthalmic Res"},{"issue":"12","key":"10.1016\/j.ajo.2016.07.016_bib20","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1136\/ard.2006.052092","article-title":"Efficacy of tumour necrosis factor blockers in reducing uveitis flares in patients with spondylarthropathy: a retrospective study","volume":"65","author":"Guignard","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.ajo.2016.07.016_bib21","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1097\/IAE.0000000000000624","article-title":"Long-term efficacy of systemic infliximab in recalcitrant retinal vasculitis","volume":"35","author":"Sharma","year":"2015","journal-title":"Retina"},{"issue":"6","key":"10.1016\/j.ajo.2016.07.016_bib22","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.survophthal.2015.06.004","article-title":"Anti-tumor necrosis factor-alpha therapy in uveitis","volume":"60","author":"Cordero-Coma","year":"2015","journal-title":"Surv Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2016.07.016_bib23","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1185\/030079903125002847","article-title":"Tumour necrosis factor-alpha levels in aqueous humour and serum from patients with uveitis: the involvement of HLA-B27","volume":"20","author":"Perez-Guijo","year":"2004","journal-title":"Curr Med Res Opin"},{"issue":"4","key":"10.1016\/j.ajo.2016.07.016_bib24","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","article-title":"Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria","volume":"27","author":"van der Linden","year":"1984","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.ajo.2016.07.016_bib25","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop","volume":"140","author":"Jabs","year":"2005","journal-title":"Am J Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2016.07.016_bib26","first-page":"2281","article-title":"A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index","volume":"21","author":"Calin","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ajo.2016.07.016_bib27","series-title":"Global Tuberculosis Control 2011","author":"World Health Organization","year":"2011"},{"issue":"12","key":"10.1016\/j.ajo.2016.07.016_bib28","first-page":"1342","article-title":"The role of TST in the diagnosis of latent tuberculosis infection among military personnel in South Korea","volume":"10","author":"Choi","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"issue":"8","key":"10.1016\/j.ajo.2016.07.016_bib29","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/rheumatology\/kel030","article-title":"Tumour necrosis factor alpha inhibitors in the treatment of childhood uveitis","volume":"45","author":"Saurenmann","year":"2006","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.ajo.2016.07.016_bib30","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1136\/ard.2006.058248","article-title":"Infliximab and etanercept in the treatment of chronic uveitis associated with refractory juvenile idiopathic arthritis","volume":"66","author":"Tynjala","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.ajo.2016.07.016_bib31","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1136\/ard.2008.092585","article-title":"Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a prospective open-label study","volume":"68","author":"Rudwaleit","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.ajo.2016.07.016_bib32","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1396-0296.2004.04044.x","article-title":"Infliximab","volume":"17","author":"Winterfield","year":"2004","journal-title":"Dermatol Ther"},{"issue":"6","key":"10.1016\/j.ajo.2016.07.016_bib33","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1002\/art.39667","article-title":"Infliximab versus adalimumab in the treatment of refractory inflammatory uveitis: a multicenter study from the French Uveitis Network","volume":"68","author":"Vallet","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"10","key":"10.1016\/j.ajo.2016.07.016_bib34","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1002\/art.22918","article-title":"Do tumor necrosis factor inhibitors cause uveitis? A registry-based study","volume":"56","author":"Lim","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ajo.2016.07.016_bib35","doi-asserted-by":"crossref","first-page":"2014471319","DOI":"10.1155\/2014\/471319","article-title":"Inefficacy or paradoxical effect? Uveitis in ankylosing spondylitis treated with etanercept","volume":"2014","author":"Raffeiner","year":"2014","journal-title":"Case Rep Med"},{"issue":"7","key":"10.1016\/j.ajo.2016.07.016_bib36","first-page":"1362","article-title":"Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behcet's disease with refractory uveoretinitis","volume":"31","author":"Ohno","year":"2004","journal-title":"J Rheumatol"},{"issue":"7","key":"10.1016\/j.ajo.2016.07.016_bib37","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1093\/rheumatology\/kem101","article-title":"Long-term efficacy of infliximab in refractory posterior uveitis of Behcet's disease: a 24-month follow-up study","volume":"46","author":"Niccoli","year":"2007","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.ajo.2016.07.016_bib38","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00296-009-1213-z","article-title":"One year study of efficacy and safety of infliximab in the treatment of patients with ocular and neurological Behcet's disease refractory to standard immunosuppressive drugs","volume":"31","author":"Giardina","year":"2011","journal-title":"Rheumatol Int"},{"issue":"6","key":"10.1016\/j.ajo.2016.07.016_bib39","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/art.22351","article-title":"Pulmonary sarcoidosis developing during infliximab therapy","volume":"55","author":"O'Shea","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.ajo.2016.07.016_bib40","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/art.22238","article-title":"Development of sarcoidosis during etanercept therapy","volume":"55","author":"Gonzalez-Lopez","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.ajo.2016.07.016_bib41","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.semarthrit.2006.02.001","article-title":"Tumor necrosis factor antagonists: different kinetics and\/or mechanisms of action may explain differences in the risk for developing granulomatous infection","volume":"36","author":"Furst","year":"2006","journal-title":"Semin Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.ajo.2016.07.016_bib42","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/rheumatology\/kep046","article-title":"Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 cases","volume":"48","author":"Daien","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.ajo.2016.07.016_bib43","doi-asserted-by":"crossref","first-page":"349","DOI":"10.4046\/trd.2015.78.4.349","article-title":"The prevalence rate of tuberculin skin test positive by contacts group to predict the development of active tuberculosis after school outbreaks","volume":"78","author":"Kim","year":"2015","journal-title":"Tuberc Respir Dis (Seoul)"},{"issue":"5","key":"10.1016\/j.ajo.2016.07.016_bib44","doi-asserted-by":"crossref","first-page":"340","DOI":"10.7326\/0003-4819-146-5-200703060-00006","article-title":"Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research","volume":"146","author":"Menzies","year":"2007","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1016\/j.ajo.2016.07.016_bib45","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.3899\/jrheum.150057","article-title":"The risk of tuberculosis in patients with rheumatoid arthritis treated with tumor necrosis factor-alpha antagonist: a metaanalysis of both randomized controlled trials and registry\/cohort studies","volume":"42","author":"Ai","year":"2015","journal-title":"J Rheumatol"},{"issue":"15","key":"10.1016\/j.ajo.2016.07.016_bib46","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa011110","article-title":"Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent","volume":"345","author":"Keane","year":"2001","journal-title":"N Engl J Med"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939416303609?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939416303609?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:32:04Z","timestamp":1757597524000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939416303609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":46,"alternative-id":["S0002939416303609"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2016.07.016","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-TNF\u03b1 Treatment for HLA-B27-Positive Ankylosing Spondylitis\u2013Related Uveitis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2016.07.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}